These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2706131)

  • 21. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
    Roubidoux MA; Bailey JE; Wray LA; Helvie MA
    Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubular breast cancer experience at Washington University: a review of the literature.
    Holland DW; Boucher LD; Mortimer JE
    Clin Breast Cancer; 2001 Oct; 2(3):210-4. PubMed ID: 11899414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
    Erhardt K; Auer GU
    Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
    Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
    Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence.
    Hatschek T; Gröntoft O; Fagerberg G; Stål O; Sullivan S; Carstensen J; Nordenskjöld B
    Breast Cancer Res Treat; 1990 May; 15(3):149-60. PubMed ID: 2196942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
    Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program.
    Hatschek T; Fagerberg G; Stål O; Sullivan S; Carstensen J; Gröntoft O; Nordenskjöld B
    Cancer; 1989 Sep; 64(5):1074-81. PubMed ID: 2758384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of breast consistency at palpation with breast density at mammography.
    Boren WL; Hunter TB; Bjelland JC; Hunt KR
    Invest Radiol; 1990 Sep; 25(9):1010-1. PubMed ID: 2211041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
    Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
    Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental and clinical study on flow cytometric DNA analysis of human breast carcinoma].
    Nakamura A
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):737-46. PubMed ID: 3412305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
    Chang HR; Cole B; Bland KI
    J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palpable presentation of breast cancer persists in the era of screening mammography.
    Mathis KL; Hoskin TL; Boughey JC; Crownhart BS; Brandt KR; Vachon CM; Grant CS; Degnim AC
    J Am Coll Surg; 2010 Mar; 210(3):314-8. PubMed ID: 20193894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study.
    Tweedie E; Tonkin K; Kerkvliet N; Doig GS; Sparrow RK; O'Malley FP
    Clin Invest Med; 1997 Oct; 20(5):300-7. PubMed ID: 9336655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-resolution 2-dimensional protein mapping of "diploid" and "aneuploid" mammary adenocarcinomas.
    Steinbeck R; Steinbeck C; Postel E; Busse H; Havsteen B; Auer G
    Histochemistry; 1986; 84(4-6):338-41. PubMed ID: 3721908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentric mammary carcinoma: evidence of monoclonal proliferation.
    Middleton LP; Vlastos G; Mirza NQ; Eva S; Sahin AA
    Cancer; 2002 Apr; 94(7):1910-6. PubMed ID: 11932891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DNA profile of breast cancer in situ.
    Pallis L; Skoog L; Falkmer U; Wilking N; Rutquist LE; Auer G; Cedermark B
    Eur J Surg Oncol; 1992 Apr; 18(2):108-11. PubMed ID: 1582502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen receptors in primary breast neoplasms].
    Tsyrlina EV; Moiseenko VM; Boronoeva TR; Semiglazov VF
    Vopr Onkol; 1984; 30(4):29-33. PubMed ID: 6328757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.